A. B. Majumder et al. / Bioorg. Med. Chem. Lett. 18 (2008) 124–128
127
Table 4. Synthesis of (R)-2-octyl-b-D-galactopyranoside in 20%
DMSO (v/v) in acetonitrile
7. Gupta, M. N. Eur. J. Biochem. 1992, 203, 25.
8. Partridge, J.; Harper, N.; Moore, B. D.; Halling, P. J. In
Methods in Biotechnology; Vulfson, E. N., Halling, P. J.,
Holland, H. L., Eds.; Humana Press: New Jersey, 2002; p
a
C (%) de
a
a
S
a
Biocatalyst type Initial rate
P
ee
E
À1 À1
(
lmol mg
h
)
(10 h)
(%)
(%)
9
7.
. Lee, M. Y.; Dordick, J. S. Curr. Opin. Biotechnol. 2002,
3, 376.
Lyophiliized
Co-lyophilized
EPRP
534
735
936
17
21
27
30
72
78
88
90
14
20
32
38
7
9
10
21
28
1
1
1
1
0. Hudson, E. P.; Eppler, R. K.; Clark, D. S. Curr. Opin.
Biochem. 2005, 16, 637.
1. Shah, S.; Gupta, M. N. Bioorg. Med. Chem. Lett. 2007, 17,
b
EPRP
1206
Variation of initial rates and enantioselectivity of the different for-
mulations of b-galactosidase. Each reaction set was performed twice
and the deviations between the pair of readings were within 2%.
9
21.
2. Griebenow, K.; Laureano, Y. D.; Santos, A. M.; Cle-
mente, I. M.; Rodriguez, L.; Vidal, M. W.; Barletta, G.
J. Am. Chem. Soc. 1999, 121, 8157.
a
C, de
P
, ee
S
, E bear the sam meanings as described in Table 1.
b
The solvent used in this case for the reaction was 100% DMSO.
1
1
3. Hirata, T.; Shimoda, K.; Fujino, T.; Yamane, S-Y.; Ohta,
S. Bull. Chem. Soc. Jpn. 2001, 74, 539.
4. Preparation of different formulations of the biocatalyst
for low-water media: Lyophilized enzyme preparation:
b-Galactosidase powder (5 mg) was dissolved in
in 4 h is a considerable improvement as compared to
1
9
.5% conversion reported by Bridiau et al. and 39%
conversion with a de (reported as ee) of 98% (corre-
P
3
3
200 lL of 100 mM phosphate buffer (pH 7.3),
sponding E = 188) reported by Matsumura et al. For
frozen at À23 °C, and was lyophilized for 24 h. In
another case, the same amount of enzyme was
dissolved along with galactose (18.6 mg) and was
lyophilized for 24 h.
galactosylation of racemic 2-octanol, again EPRP was
found to be better than the other formulations of b-
galactosidase (Table 4). Under optimized conditions,
3
high 92% de which is a considerable improvement over
the earlier reported value of 63% de . The present work
P
outlines an optimization strategy which combines the
use of a highly active biocatalyst with a suitable reaction
medium for the diastereoselective galactosylation of sec-
ondary alcohols.
3% conversion was achieved within 10 h with a fairly
EPRP (enzyme precipitated and rinsed with propanol):
25 lL of enzyme solution (20 mg/100 lL of 100 mM
phosphate buffer, pH 7.3) was precipitated in 200 lL
of ice cold dry n-propanol, centrifuged, and the
recovered pellet was repeatedly rinsed with n-propa-
nol before using for the reaction.
P
3
1
5. b-Galactosylation with 1-phenylethanol: In screw-capped
vials, D-galactose (18.5 mg) and 25 lL of racemic 1-
phenylethanol (Merck, Germany) were dissolved in a
solution of acetonitrile, DMF, water (in 9:0.5:0.5, v/v
ratio) so that the final volume of the reaction volume was
Acknowledgments
1
.0 mL. After pre-incubation at 55 °C for 15 min, 5 mg
The authors are grateful to Dr. N. G. Ramesh (Chemis-
try Department, IIT Delhi) for helpful discussions. This
work was supported by ‘Core group grant for applied
biocatalysis’ by Department of Science and Technology,
Government of India (DST). The financial supports
provided by Council of Scientific and Industrial Re-
search (India) to ABM as Senior Research Fellowship
are also gratefully acknowledged.
(10%, w/w reactants) enzyme preparation was added. As
an alternative reaction medium, anhydrous DMSO (water
content <0.005%, v/v, Acros Organics, USA) was tried
instead of DMF and water. The reaction was carried out
at 55 °C at 200 rpm in an orbital shaker. b-Galactosylation
with 2-octanol: D-Galactose (18.5 mg) and 35 lL of race-
mic 2-octanol (Merck, Germany) were dissolved in a
solution of acetonitrile, DMSO (in 4: 1, v/v ratio) and the
reaction was performed as mentioned earlier.
1
6. HPLC analysis and determination of the diastereomeric
excess (de) of the product: The product analysis was done
with chiral column [Chiracel OD RH; eluents: (i) hexane/
isopropanol/ethanol = 75:23:2 (v/v) at a flow rate of
Supplementary data
0
.5 mL/min by DAD-UV (217 nm) for 1-phenylethanol
system, (ii) acetonitrile/water = 9:1 (v/v) at a flow rate of
.25 mL/min by RID for 2-octanol system] fitted in
0
Agilent 1100 series HPLC system. The peaks (retention
time) were identified as (S)-1-phenylethyl-b-D-galactopy-
ranoside (4.43 min), (R)-1-phenylethyl-b-D-galactopyran-
oside (4.68 min), (R)-1-phenylethanol (4.90 min), (S)-1-
phenylethanol (5.06 min), and (S)-2-octyl-b-D-galactopy-
ranoside (8.75 min), (R)-2-octyl-b-D-galactopyranoside
References and notes
. Bridiau, N.; Taboubi, S.; Marzouki, N.; Legoy, M. D.;
Maugard, T. Biotechnol. Prog. 2006, 22, 326.
1
(
9.20 min), (R)-2-octanol (10.04 min), (S)-2-octanol
10.3 min). Finally, the enantioselectivity was calculated
2
3
. Oosterom, M. W-. V.; van Belle, H. J. A.; van
Rantwijk, F.; Sheldon, R. A. J. Mol. Catal. A: Chem.
(
by Chen’s equation.
2
3
1
998, 134, 267.
1
1
1
2
7. Anchordogny, T. J.; Carpenter, J. F. Arch. Biochem.
Biophys. 1996, 332, 231.
8. Mishra, P.; Griebenow, K.; Klibanov, A. M. Biotechnol.
Bioeng. 1996, 52, 609.
9. Partridge, J.; Halling, P. J.; Moore, B. D. J. Chem. Soc.,
Chem. Commun. 1998, 7, 841.
0. Roy, I.; Gupta, M. N. Bioorg. Med. Chem. Lett. 2004, 14,
. Matsumura, S.; Yamazaki, H.; Toshima, K. Biotechnol.
Lett. 1997, 19, 583.
4
5
. Vic, G.; Crout, D. H. G. Carbohydr. Res. 1995, 279, 315.
. Garcia-Garibay, M.; Lopez-Munguia, A.; Berzana, E.
Biotechnol. Bioeng. 2000, 69, 627.
6
. Vic, G.; Biton, J.; Le Beller, D.; Michael, J.-M.; Thomas,
D. Biotechnol. Bioeng. 1995, 46, 109.
2
191.